Matches in SemOpenAlex for { <https://semopenalex.org/work/W2979762208> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W2979762208 abstract "Introduction: Beta interferon (IFN-β) is known as the first-line therapy in relapsing-remitting multiple sclerosis (RRMS). Recent studies have shown different effects of IFN-β on brain-derived neurotrophic factor (BDNF) serum levels. Given the known role of BDNF in the restoration and conservation of the nervous system, this study was designed to investigate the possible effect of this drug through stimulating BDNF production. Objectives: Impressible treatments for progressive multiple sclerosis (MS) are still being sought. Individual response to existing treatments for MS varies significantly among patients while the risk of serious adverse events remains an issue, especially for the novel drugs. Patients and Methods: In this clinical trial, 96 patients newly diagnosed with RRMS were studied within three months, in 3 groups of 32 subjects. Each group received one of the foregoing drugs (Avonex, Rebif and Betaferon). BDNF levels were compared between different groups at the end. Results: BDNF serum concentration in all groups was significantly different (P<0.001) compared to baseline after 3 months. And comparison between groups showed a significant difference between the groups receiving Betaferon (IFN-β1b) (P=0.001) and Rebif (P=0.002) compared to the other groups. Avonex compared with either control or Betaferon (IFN-β1b) and Rebif groups showed no significant difference. Also the correlation between the mean changes in expanded disability status scale (EDSS) and BDNF was not observed (r = -0.189, P=0.065). Conclusions: Significant difference in BDNF levels were observed between groups." @default.
- W2979762208 created "2019-10-18" @default.
- W2979762208 creator A5005159310 @default.
- W2979762208 creator A5009934360 @default.
- W2979762208 creator A5013782925 @default.
- W2979762208 creator A5024277931 @default.
- W2979762208 creator A5048874986 @default.
- W2979762208 creator A5088857757 @default.
- W2979762208 date "2019-06-22" @default.
- W2979762208 modified "2023-09-25" @default.
- W2979762208 title "The effect of interferon-β therapy on brain-derived neurotrophic factor serum concentration in relapsing— remitting multiple sclerosis: a randomized clinical trial" @default.
- W2979762208 doi "https://doi.org/10.15171/ipp.2019.14" @default.
- W2979762208 hasPublicationYear "2019" @default.
- W2979762208 type Work @default.
- W2979762208 sameAs 2979762208 @default.
- W2979762208 citedByCount "0" @default.
- W2979762208 crossrefType "journal-article" @default.
- W2979762208 hasAuthorship W2979762208A5005159310 @default.
- W2979762208 hasAuthorship W2979762208A5009934360 @default.
- W2979762208 hasAuthorship W2979762208A5013782925 @default.
- W2979762208 hasAuthorship W2979762208A5024277931 @default.
- W2979762208 hasAuthorship W2979762208A5048874986 @default.
- W2979762208 hasAuthorship W2979762208A5088857757 @default.
- W2979762208 hasBestOaLocation W29797622081 @default.
- W2979762208 hasConcept C126322002 @default.
- W2979762208 hasConcept C160539049 @default.
- W2979762208 hasConcept C170493617 @default.
- W2979762208 hasConcept C197934379 @default.
- W2979762208 hasConcept C203014093 @default.
- W2979762208 hasConcept C2778790584 @default.
- W2979762208 hasConcept C2780640218 @default.
- W2979762208 hasConcept C2910198813 @default.
- W2979762208 hasConcept C2994247566 @default.
- W2979762208 hasConcept C3018023364 @default.
- W2979762208 hasConcept C535046627 @default.
- W2979762208 hasConcept C71924100 @default.
- W2979762208 hasConcept C90924648 @default.
- W2979762208 hasConceptScore W2979762208C126322002 @default.
- W2979762208 hasConceptScore W2979762208C160539049 @default.
- W2979762208 hasConceptScore W2979762208C170493617 @default.
- W2979762208 hasConceptScore W2979762208C197934379 @default.
- W2979762208 hasConceptScore W2979762208C203014093 @default.
- W2979762208 hasConceptScore W2979762208C2778790584 @default.
- W2979762208 hasConceptScore W2979762208C2780640218 @default.
- W2979762208 hasConceptScore W2979762208C2910198813 @default.
- W2979762208 hasConceptScore W2979762208C2994247566 @default.
- W2979762208 hasConceptScore W2979762208C3018023364 @default.
- W2979762208 hasConceptScore W2979762208C535046627 @default.
- W2979762208 hasConceptScore W2979762208C71924100 @default.
- W2979762208 hasConceptScore W2979762208C90924648 @default.
- W2979762208 hasLocation W29797622081 @default.
- W2979762208 hasOpenAccess W2979762208 @default.
- W2979762208 hasPrimaryLocation W29797622081 @default.
- W2979762208 hasRelatedWork W1964826416 @default.
- W2979762208 hasRelatedWork W1969036386 @default.
- W2979762208 hasRelatedWork W1971181731 @default.
- W2979762208 hasRelatedWork W1975747207 @default.
- W2979762208 hasRelatedWork W1982500633 @default.
- W2979762208 hasRelatedWork W2003281803 @default.
- W2979762208 hasRelatedWork W2008009277 @default.
- W2979762208 hasRelatedWork W2028903202 @default.
- W2979762208 hasRelatedWork W2082743251 @default.
- W2979762208 hasRelatedWork W2084484056 @default.
- W2979762208 hasRelatedWork W2149770029 @default.
- W2979762208 hasRelatedWork W2275856918 @default.
- W2979762208 hasRelatedWork W2566842233 @default.
- W2979762208 hasRelatedWork W2571794954 @default.
- W2979762208 hasRelatedWork W2599708162 @default.
- W2979762208 hasRelatedWork W2602821845 @default.
- W2979762208 hasRelatedWork W2794519623 @default.
- W2979762208 hasRelatedWork W2898895136 @default.
- W2979762208 hasRelatedWork W2982228736 @default.
- W2979762208 hasRelatedWork W3181271812 @default.
- W2979762208 isParatext "false" @default.
- W2979762208 isRetracted "false" @default.
- W2979762208 magId "2979762208" @default.
- W2979762208 workType "article" @default.